Publications by authors named "Xiangying Zhu"

The major challenge of recombinant adeno-associated virus (rAAV) vectors is host immunological barriers. Compared to the neutralizing antibody and the cytotoxic T lymphocyte response, the host immune responses induced by unsatisfactory rAAV manufacturing were largely ignored previously. rAAV vector production usually requires large amounts of plasmid DNAs.

View Article and Find Full Text PDF

Purpose: To determine the diagnostic efficiency of the ATA classification and ultrasound-guided fine-needle aspiration (FNA) results in identifying the risk factors of malignancy, we analyzed the thyroid nodules of patients who underwent thyroidectomy and compared preoperative ATA classifications with FNA results.

Methods: We retrospectively analyzed 274 nodules of 196 patients who underwent ultrasonography, FNA and thyroidectomy. Histopathological findings of thyroid nodules were considered as the Au standard in the analysis of the diagnostic efficiency of the ATA classification and FNA results.

View Article and Find Full Text PDF

Colon cancer is one of the major causes of cancer mortality worldwide. However, the underlying mechanism and therapeutic targets of colon cancer have not yet been fully elucidated. In the present study, we demonstrate that citron rho-interacting, serine/threonine kinase 21 (CIT) promotes the growth of human colon cancer cells.

View Article and Find Full Text PDF

Combining results from previous studies, a multi-epitope antigen PCXZ against the hepatitis C virus was synthesized in this study. The antigenic specificity of PCXZ was determined by recognizing antibodies in serum samples from hepatitis C virus patients, but not from healthy subjects or subjects who had the hepatitis B virus. The characteristics of PCXZ immunogenicity were evaluated in BALB/c mice.

View Article and Find Full Text PDF
Article Synopsis
  • Attenuated Salmonella typhimurium can boost immune responses and target solid tumors, making it promising for vaccines and cancer therapies.
  • The Type III secretion system of Salmonella helps overcome issues with antigen presentation by delivering proteins outside the cells.
  • A new vaccine using this system and Heat Shock Protein 70 (Hsp70) was tested in mice, effectively breaking immune tolerance and promoting a targeted immune response against melanoma.
View Article and Find Full Text PDF

Genes encoding purine nucleoside phosphorylase (deo D), uridine phosphorylase (udp) and thimidine phosphorylase (deo A) from Escherichia coli BL21 were cloned and overexpressed in E. coli DH5alpha. The recombinant strains were employed to synthesize 2'-deoxyadenosine (dAR) and 6-methylpurine-2'-deoxyriboside (MePdR).

View Article and Find Full Text PDF

Therapeutic vaccines of cancer are attractive for their capacity of breaking the immune tolerance and invoking long-term immune response targeting cancer cells without autoimmunity. An efficient antigen delivery system is the key issue of developing an effective cancer vaccine. Attenuated Salmonella typhimurium as the carrier of cancer vaccine are able to transfer DNA from the prokaryote to the eukaryote and preferentially replicate within the tumor tissue.

View Article and Find Full Text PDF

hTERT (human telomerase reverse transcriptase) plays a key role in the process of cell immortalization. Overexpression of hTERT has been implicated in 85% of malignant tumors and offers a specific target for cancer therapy. In this paper, we describe an effective approach using a single-chain variable fragment (scFv) intrabody derived from monoclonal hybridoma directed against hTERT to attenuate the immortalization of human uterine cervix and hepatoma cells.

View Article and Find Full Text PDF
Article Synopsis
  • RNA interference (RNAi) has potential as a therapeutic method to silence disease-related genes and has been effectively used in genomic research.
  • Attenuated S. typhimurium can deliver short hairpin RNA (shRNA) vectors into mammalian cells, successfully inducing RNAi in lab settings and live organisms.
  • When administered orally, S. typhimurium carrying shRNA targeting the bcl2 gene led to significant gene silencing in melanoma cells, resulting in delayed tumor growth and increased survival in mouse models, indicating a promising cancer treatment method.
View Article and Find Full Text PDF